BCR::ABL1-negative myeloproliferative neoplasms (MPN) comprise a heterogeneous group of hematological neoplastic diseases that is characterized by cytosis of one or more cell lineages in the peripheral blood, associated with a significant risk of developing a secondary acute myeloid leukemia (sAML) [1]. This evidence concerns the gene BCR and myeloproliferative disorder.